CN Patent

CN104507309A — 用于棘白菌素类化合物的给药方案

Assigned to Nap Pharmaceutical Group Co ltd · Expires 2015-04-08 · 11y expired

What this patent protects

本发明的特征是药物组合物、方法和药盒，其特征在于用于给予棘白菌素类化合物的给药方案和口服剂量制剂。

USPTO Abstract

本发明的特征是药物组合物、方法和药盒，其特征在于用于给予棘白菌素类化合物的给药方案和口服剂量制剂。

Drugs covered by this patent

rezafungin-acetate (REZAFUNGIN ACETATE)

Patent Metadata

Patent number: CN104507309A
Jurisdiction: CN
Classification: —
Expires: 2015-04-08
Drug substance claim: No
Drug product claim: No
Assignee: Nap Pharmaceutical Group Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.